These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20970406)

  • 21. Role of NAD(P)H:quinone oxidoreductase in the progression of neuronal cell death in vitro and following cerebral ischaemia in vivo.
    Kapinya KJ; Harms U; Harms C; Blei K; Katchanov J; Dirnagl U; Hörtnagl H
    J Neurochem; 2003 Mar; 84(5):1028-39. PubMed ID: 12603827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid I and attenuates its nephrotoxicity.
    Chen M; Gong L; Qi X; Xing G; Luan Y; Wu Y; Xiao Y; Yao J; Li Y; Xue X; Pan G; Ren J
    Toxicol Sci; 2011 Aug; 122(2):288-96. PubMed ID: 21613233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer-associated variants of human NQO1: impacts on inhibitor binding and cooperativity.
    Megarity CF; Timson DJ
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31431515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dicoumarol inhibits rat NAD(P)H:quinone oxidoreductase in vitro and induces its expression in vivo.
    Stiborova M; Levova K; Barta F; Dracinska H; Sulc M; Hodek P; Frei E; Arlt VM; Schmeiser HH
    Neuro Endocrinol Lett; 2014; 35 Suppl 2():123-32. PubMed ID: 25638376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A physiological threshold for protection against menadione toxicity by human NAD(P)H:quinone oxidoreductase (NQO1) in Chinese hamster ovary (CHO) cells.
    De Haan LH; Boerboom AM; Rietjens IM; van Capelle D; De Ruijter AJ; Jaiswal AK; Aarts JM
    Biochem Pharmacol; 2002 Dec; 64(11):1597-603. PubMed ID: 12429349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NADPH quinone oxidoreductase 1 mediates breast cancer cell resistance to thymoquinone-induced apoptosis.
    Sutton KM; Doucette CD; Hoskin DW
    Biochem Biophys Res Commun; 2012 Sep; 426(3):421-6. PubMed ID: 22960073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and evaluation of (±)-dunnione and its ortho-quinone analogues as substrates for NAD(P)H:quinone oxidoreductase 1 (NQO1).
    Bian J; Xu L; Deng B; Qian X; Fan J; Yang X; Liu F; Xu X; Guo X; Li X; Sun H; You Q; Zhang X
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1244-8. PubMed ID: 25677663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo.
    Dehn DL; Siegel D; Zafar KS; Reigan P; Swann E; Moody CJ; Ross D
    Mol Cancer Ther; 2006 Jul; 5(7):1702-9. PubMed ID: 16891456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1).
    Bian J; Deng B; Xu L; Xu X; Wang N; Hu T; Yao Z; Du J; Yang L; Lei Y; Li X; Sun H; Zhang X; You Q
    Eur J Med Chem; 2014 Jul; 82():56-67. PubMed ID: 24874653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antioxidant response induced by serum withdrawal protects HL-60 cells against inhibition of NAD(P)H:quinone oxidoreductase 1.
    Gómez-Díaz C; Bello RI; López-Lluch G; Forthoffer N; Navas P; Villalba JM
    Biofactors; 2003; 18(1-4):219-28. PubMed ID: 14695937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NAD(P)H:quinone oxidoreductase 1 (NQO1) localizes to the mitotic spindle in human cells.
    Siegel D; Kepa JK; Ross D
    PLoS One; 2012; 7(9):e44861. PubMed ID: 22984577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxicity of RH1: NAD(P)H:quinone acceptor oxidoreductase (NQO1)-independent oxidative stress and apoptosis induction.
    Tudor G; Alley M; Nelson CM; Huang R; Covell DG; Gutierrez P; Sausville EA
    Anticancer Drugs; 2005 Apr; 16(4):381-91. PubMed ID: 15746574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NAD(P)H:quinone oxidoreductase-1-dependent and -independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors.
    Han Y; Shen H; Carr BI; Wipf P; Lazo JS; Pan SS
    J Pharmacol Exp Ther; 2004 Apr; 309(1):64-70. PubMed ID: 14718602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Affinity-based small fluorescent probe for NAD(P)H:quinone oxidoreductase 1 (NQO1). Design, synthesis and pharmacological evaluation.
    Bian J; Li X; Xu L; Wang N; Qian X; You Q; Zhang X
    Eur J Med Chem; 2017 Feb; 127():828-839. PubMed ID: 27829520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Inhibition Kinetics and Potential Anti-Migration Activity of NQO1 Inhibitory Coumarins on Cholangiocarcinoma Cells.
    Khunluck T; Kukongviriyapan V; Senggunprai L; Duangarsong W; Prawan A
    Integr Cancer Ther; 2019; 18():1534735418820444. PubMed ID: 30584780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of indolequinone mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1): NQO1 inhibition and growth inhibitory activity in human pancreatic MIA PaCa-2 cancer cells.
    Reigan P; Colucci MA; Siegel D; Chilloux A; Moody CJ; Ross D
    Biochemistry; 2007 May; 46(20):5941-50. PubMed ID: 17455910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors Necrostatin-1 (Nec-1) and 7-Cl-O-Nec-1 (Nec-1s) are potent inhibitors of NAD(P)H: Quinone oxidoreductase 1 (NQO1).
    Yu J; Zhong B; Zhao L; Hou Y; Wang X; Chen X
    Free Radic Biol Med; 2021 Sep; 173():64-69. PubMed ID: 34252539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a novel intestinal first pass metabolic pathway: NQO1 mediated quinone reduction and subsequent glucuronidation.
    Hao H; Wang G; Cui N; Li J; Xie L; Ding Z
    Curr Drug Metab; 2007 Feb; 8(2):137-49. PubMed ID: 17305492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities.
    Ling Y; Yang QX; Teng YN; Chen S; Gao WJ; Guo J; Hsu PL; Liu Y; Morris-Natschke SL; Hung CC; Lee KH
    Eur J Med Chem; 2018 Jun; 154():199-209. PubMed ID: 29803003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization and partial purification of microsomal NAD(P)H:quinone oxidoreductases.
    Jaiswal AK
    Arch Biochem Biophys; 2000 Mar; 375(1):62-8. PubMed ID: 10683249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.